
EXPERTISE
Management Consulting
Corporate Advisory
Data-driven solutions
Operational Efficiencies
Anti-money Laundering (AML)
Project Management

Senior Consultant
New York
212-766-0001
EXPERTISE
Management Consulting
Corporate Advisory
Data-driven solutions
Operational Efficiencies
Anti-money Laundering (AML)
Project Management
Joshua Gubitz, Senior Consultant, is a data analytics professional and project manager with 20+ years of experience focusing on data-driven solutions, interim management, financial crime compliance (FCC), and anti-money laundering (AML). Notable companies Mr. Gubitz has worked for include HSBC, KCI, and Pfizer.
Among his accomplishments, Gubitz served as acting CFO for the Japanese subsidiary of a $2 billion global medical device company and helped them grow their Japan revenue from $0 to $30 million in 18 months. He built and led the data analytics team for the Monitorship of a major global financial institution, conducting money-laundering investigations in over 20 countries. He also led the overhaul of marketing operations for a Fortune 100 pharmaceutical company in response to an FDA mandate, and also managed the creation of a new department to administer over $100 million in annual medical education grants for a Fortune 100 pharmaceutical company. Mr. Gubitz holds an MBA in Finance from Boston University, an MA from the University of Washington, and a BA from New York University.
Joshua Gubitz, Senior Consultant, is a data analytics professional and project manager with 20+ years of experience focusing on data-driven solutions, interim management, financial crime compliance (FCC), and anti-money laundering (AML). Notable companies Mr. Gubitz has worked for include HSBC, KCI, and Pfizer.
Among his accomplishments, Gubitz served as acting CFO for the Japanese subsidiary of a $2 billion global medical device company and helped them grow their Japan revenue from $0 to $30 million in 18 months. He built and led the data analytics team for the Monitorship of a major global financial institution, conducting money-laundering investigations in over 20 countries. He also led the overhaul of marketing operations for a Fortune 100 pharmaceutical company in response to an FDA mandate, and also managed the creation of a new department to administer over $100 million in annual medical education grants for a Fortune 100 pharmaceutical company. Mr. Gubitz holds an MBA in Finance from Boston University, an MA from the University of Washington, and a BA from New York University.